These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8560284

  • 1. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
    Kattamis CA, Kattamis AC.
    Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
    [No Abstract] [Full Text] [Related]

  • 2. Iron chelating therapy in thalassemia: current problems.
    Russo G.
    Haematologica; 1990 Oct; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract] [Full Text] [Related]

  • 3. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C, Zurlo MG, DeStefano P, Boffa C, DeSanctis V, DiPalma A, DiGregorio L, Melevendi C, Piga A, Sabato V.
    Bone Marrow Transplant; 1993 Oct; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract] [Full Text] [Related]

  • 4. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ, Grady RW.
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [Abstract] [Full Text] [Related]

  • 5. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E, Baronciani D, Lucarelli G, Giardini C, Galimberti M, Polchi P, Martinelli F, Baldassarri M, Muretto P.
    Bone Marrow Transplant; 1993 Oct; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
    Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tönz O, Zurbrügg RP.
    Helv Paediatr Acta; 1979 Oct; 34(3):197-207. PubMed ID: 500381
    [Abstract] [Full Text] [Related]

  • 12. The management of haemoglobinopathies.
    Davies SC, Wonke B.
    Baillieres Clin Haematol; 1991 Apr; 4(2):361-89. PubMed ID: 1912665
    [No Abstract] [Full Text] [Related]

  • 13. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK, Lim SL, Tan WC, Ong EE, Goh AS.
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The endocrine complications in thalassemia major].
    Anastasi S, Caruso V, Magnano C, Leocata A.
    Pediatr Med Chir; 1991 Jun; 13(1):63-5. PubMed ID: 2052458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Critical appraisal of growth retardation and pubertal disturbances in thalassemia.
    Chatterjee R, Bajoria R.
    Ann N Y Acad Sci; 2010 Aug; 1202():100-14. PubMed ID: 20712780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.